56712 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 

The estimated burden associated with 

the information collection requirements 

for these provisions is 2,114 hours. 

Dated: September 22, 2005. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. 05–19394 Filed 9–27–05; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–04–4007] 

Memorandum of Understanding 

between the Food and Drug 

Administration, Forensic Chemistry 

Center and the Federal Bureau of 

Investigation 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the Food 

and Drug Administration and the 

Federal Bureau of Investigation (FBI). 

The purpose of this MOU is to establish 

the general policies and procedures that 

will govern administrative, logistical, 

and operational support to FBI missions 

including cost reimbursable activities. 

DATES: The agreement became effective 

December 22, 2004. 

FOR FURTHER INFORMATION CONTACT:

For the FDA: Fred Fricke, Food and 

Drug Administration, Forensic 

Chemistry Center, 6751 Steger Dr., 

Cincinnati, OH 45237, 513–679–

2700. 

For the FBI: David L. Wilson, Federal 

Bureau of Investigation Laboratory, 

Chemical Biological Sciences Unit, 

Quantico, VA 22135, 703–632–

7766. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: September 20, 2005. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S 

Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 56713 


EN28SE05.031</GPH>
56714 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 


EN28SE05.032</GPH>
Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 56715 


EN28SE05.033</GPH>
56716 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 


EN28SE05.034</GPH>
Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 56717 


EN28SE05.035</GPH>
56718 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 


EN28SE05.036</GPH>
Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 56719 


EN28SE05.037</GPH>
56720 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 

[FR Doc. 05–19339 Filed 9–27–05; 8:45 am] 

BILLING CODE 4160–01–C 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–05–3000] 

Memorandum of Understanding 

Between the Food and Drug 

Administration and the National 

Library of Medicine 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between the Food 

and Drug Administration and the 

National Library of Medicine (NLM). 

The purpose of this MOU is to assign 

responsibilities to FDA’s Center for Drug 

Evaluation and Research (CDER) and 

NLM for the distribution of product 

labeling. 

DATES: The agreement became effective 

July 6, 2005, and supplements the 

agreement signed and dated November 

21, 2001, and December 3, 2001, by 

NLM and CDER representatives, 

respectively. 

FOR FURTHER INFORMATION CONTACT: 

For FDA: Lisa Stockbridge, Food and 

Drug Administration (HFD–140), 

5600 Fishers Lane, Rockville, MD 

20857, 301–827–7761; or Catherine 

Miller, Food and Drug 

Administration (HFD–140), 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–7772. 

For NLM: Simon Liu, Bldg. 38A, rm. 

2N221, 8600 Rockville Pike, 

Bethesda, MD 20894, 301–402–

1698; or Stuart Nelson, Bldg. 38A, 

rm. B2E17, 8600 Rockville Pike, 

Bethesda, MD 20894, 301–496–

1495. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOU’s between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: September 20, 2005. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S 


EN28SE05.038</GPH>